Tichelbäcker, T.
Dumitrescu, D.
Gerhardt, F.
Stern, D.
Wissmüller, M.
Adam, M.
Schmidt, T.
Frerker, C.
Pfister, R.
Halbach, M.
Baldus, S.
Rosenkranz, S.
Article History
First Online: 16 July 2019
Compliance with ethical guidelines
:
: T. Tichelbäcker, M. Wissmüller, C. Frerker, M. Halbach, and S. Baldus declare that they have no competing interests. D. Dumitrescu declares honoraria for lectures and/or consultancy from Actelion, Bayer, GSK, Novartis, Pfizer, Servier; participation in clinical trials for Actelion, Bayer, GSK, Novartis; and research support to institution from Actelion. F. Gerhardt declares remunerations for lectures and/or consultancy from Actelion, Bayer, GSK, MSD, and United Therapeutics; grants to institution from Actelion, Bayer, Novartis, und United Therapeutics. D. Stern declares honoraria for lectures from Actelion. M. Adam declares remunerations for lectures and/or consultancy from Edwards LifeSciences. T. Schmidt declares remunerations for lectures and/or consultancy from Edwards LifeSciences. R. Pfister declares speaker fees and travel support from Abbott Vascular, Bayer, Bristol Myers Squibb, Daiichi Sankyo, Edwards LifeSciences, Novartis, Orion Pharma, Pfizer, and Servier. S. Rosenkranz declares remunerations for lectures and/or consultancy from Abbott, Actelion, Arena, Bayer, Ferrer, GSK, MSD, Novartis, Pfizer, and United Therapeutics; research support to institution from Actelion, Bayer, Novartis, Pfizer, and United Therapeutics.
: For this article no studies with human participants or animals were performed by any of the authors. All studies performed were in accordance with the ethical standards indicated in each case.